UBS AM’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
657,209
-5,120,135
| -89% | -$8.81M | ﹤0.01% | 2358 |
|
|
2025
Q1 | $19.2M | Buy |
5,777,344
+3,869,617
| +203% | +$12.9M | ﹤0.01% | 984 |
|
|
2024
Q4 | $14.1M | Sell |
1,907,727
-39,115
| -2% | -$289K | ﹤0.01% | 1101 |
|
|
2024
Q3 | $18.3M | Sell |
1,946,842
-47,658
| -2% | -$448K | ﹤0.01% | 980 |
|
|
2024
Q2 | $16M | Buy |
1,994,500
+1,814,650
| +1,009% | +$14.6M | ﹤0.01% | 951 |
|
|
2024
Q1 | $2.67M | Sell |
179,850
-47
| -0% | -$697 | ﹤0.01% | 1536 |
|
|
2023
Q4 | $1.46M | Sell |
179,897
-1,765
| -1% | -$14.3K | ﹤0.01% | 1827 |
|
|
2023
Q3 | $827K | Buy |
181,662
+53,491
| +42% | +$243K | ﹤0.01% | 2054 |
|
|
2023
Q2 | $783K | Hold |
128,171
| – | – | ﹤0.01% | 2114 |
|
|
2023
Q1 | $783K | Hold |
128,171
| – | – | ﹤0.01% | 2114 |
|
|
2022
Q4 | $819K | Hold |
128,171
| – | – | ﹤0.01% | 1954 |
|
|
2022
Q3 | $1.23M | Sell |
128,171
-28,636
| -18% | -$274K | ﹤0.01% | 1849 |
|
|
2022
Q2 | $1.73M | Sell |
156,807
-60,728
| -28% | -$670K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $3.62M | Buy |
217,535
+39,474
| +22% | +$657K | ﹤0.01% | 1495 |
|
|
2021
Q4 | $3.4M | Buy |
178,061
+3,834
| +2% | +$73.2K | ﹤0.01% | 1596 |
|
|
2021
Q3 | $4.3M | Sell |
174,227
-1,684
| -1% | -$41.5K | ﹤0.01% | 1422 |
|
|
2021
Q2 | $4.58M | Sell |
175,911
-134,088
| -43% | -$3.49M | ﹤0.01% | 1411 |
|
|
2021
Q1 | $9.81M | Sell |
309,999
-589
| -0.2% | -$18.6K | ﹤0.01% | 1091 |
|
|
2020
Q4 | $14.4M | Buy |
310,588
+20,531
| +7% | +$953K | 0.01% | 934 |
|
|
2020
Q3 | $9.55M | Sell |
290,057
-15
| -0% | -$494 | 0.01% | 955 |
|
|
2020
Q2 | $7.96M | Buy |
290,072
+26,917
| +10% | +$739K | ﹤0.01% | 975 |
|
|
2020
Q1 | $7.88M | Buy |
263,155
+154,293
| +142% | +$4.62M | 0.01% | 922 |
|
|
2019
Q4 | $3.01M | Buy |
108,862
+27,253
| +33% | +$754K | ﹤0.01% | 1421 |
|
|
2019
Q3 | $1.49M | Buy |
81,609
+19,254
| +31% | +$350K | ﹤0.01% | 1750 |
|
|
2019
Q2 | $1.53M | Buy |
62,355
+15,370
| +33% | +$377K | ﹤0.01% | 1718 |
|
|
2019
Q1 | $447K | Hold |
46,985
| – | – | ﹤0.01% | 2153 |
|
|
2018
Q4 | $416K | Buy |
46,985
+10,677
| +29% | +$94.5K | ﹤0.01% | 2068 |
|
|
2018
Q3 | $408K | Hold |
36,308
| – | – | ﹤0.01% | 2169 |
|
|
2018
Q2 | $465K | Hold |
36,308
| – | – | ﹤0.01% | 2130 |
|
|
2018
Q1 | $614K | Buy |
36,308
+26,047
| +254% | +$440K | ﹤0.01% | 1947 |
|
|
2017
Q4 | $82.1K | Hold |
10,261
| – | – | ﹤0.01% | 2415 |
|
|
2017
Q3 | $79.5K | Hold |
10,261
| – | – | ﹤0.01% | 2375 |
|
|
2017
Q2 | $75.4K | Hold |
10,261
| – | – | ﹤0.01% | 2363 |
|
|
2017
Q1 | $76.4K | Hold |
10,261
| – | – | ﹤0.01% | 2321 |
|
|
2016
Q4 | $71K | Sell |
10,261
-17,000
| -62% | -$118K | ﹤0.01% | 2283 |
|
|
2016
Q3 | $224K | Hold |
27,261
| – | – | ﹤0.01% | 2406 |
|
|
2016
Q2 | $221K | Hold |
27,261
| – | – | ﹤0.01% | 2393 |
|
|
2016
Q1 | $138K | Buy |
27,261
+461
| +2% | +$2.33K | ﹤0.01% | 2523 |
|
|
2015
Q4 | $207K | Buy |
+26,800
| New | +$207K | ﹤0.01% | 2519 |
|